$JAZZ

Jazz Pharmaceuticals plc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$144.5 ▼-0.235%

Extented Hours

VOLUME

506,049

DAY RANGE

143.4 - 145.275

52 WEEK

126.01 - 189

Join Discuss about JAZZ with like-minded investors

profile
@Roberto_88 #decarolis
recently

beh ivan con la musica jazz di sottofondo si trada che è una bellezza!!

113 Replies 12 👍 6 🔥

profile
@HeyShoe #droscrew
recently

if you like vega and all that jazz

117 Replies 13 👍 8 🔥

profile
@HeyShoe #droscrew
recently

all that jazz

99 Replies 11 👍 6 🔥

profile
@dros #droscrew
recently

+Initiations 9/23: $ANXX $AOSL $AVDL $AVXL $BIIB $BTBT $DNMR $FSR $GTLS $HRMY $ITCI $JAZZ $JOBY $KNTE $LABP $LIDR $MCG $MRTX $OVV $OXLC $PCT $RBC $RPD $RPTX $SAGE $SFET $SITC $SWBK $UE $XFLT . -Initiations 9/23: $TSLA

103 Replies 14 👍 12 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, September 23, 2021 Futures Up/Down % Last Dow 162.00 0.47% 34,291 S&P 500 23.25 0.53% 4,407 Nasdaq 83.50 0.55% 15,247 U.S. stocks are looking at another move higher following strong gains on Wednesday despite the FOMC taking a more “hawkish” stance on both rates and the timeline on asset purchase tapering during yesterday’s meeting. Stocks jumped on Wednesday after the Federal Reserve cleared the way to ease monthly bond purchases “soon” and signaled interest rate increases may follow more quickly than expected. Stocks pared gains late as Fed Chair Jerome Powell spoke at his press conference but still closed up solidly. Fed officials indicated that they see interest rates seen rising to 1% in 2023, faster than projected by the Fed in its projections in June, and then to 1.8% in 2024. Nine of eleven major S&P 500 sectors ended the day higher. However, of note, all 11 groups retreated from the moments before Powell’s press conference began, into the close. The Dow Transport index slid to 6-month lows following weakness from Fed-Ex (FDX) earnings results and guidance the night prior. In Asian markets, The Nikkei Index was closed, the Shanghai Index rose 13 points to 3,642 and the Hang Seng Index gained 289 points to 24,510. In Europe, the German DAX is up over 130 points (0.89%) to 15,645, while the FTSE 100 rises about 20-points to move above 7,100. Oil prices are slipping but still holds near two-month high with global stockpiles tightening. In China news, the WSJ reported China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company. Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 320K 8:30 AM EST Continuing Claims…est. 2.65M 9:45 AM ET Markit Manufacturing PMI, Sept-F…est. 61.5 9:45 AM ET Markit Services PMI, Sept-F…est. 55.0 9:45 AM ET Markit Composite PMI-Sept-F 10:00 AM ET Leading Index MoM for Aug…est. +0.7% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for Sept…prior 22 Earnings Calendar: Earnings Before the Open: DRI, DYNT, IWSY, RAD Earnings After the Close: AEHR, AGTC, AIR, CAMP, $COST, MTN, $NKE, PRGS, $RSSS Other Key Events: Credit Suisse 7th Annual Oil & Gas Non-Bus Tour (virtual), 9/21-9/23 DA Davidson Diversified Industrials & Services Conference (virtual), 9/22-9/23 Goldman Sachs 30th Annual Communacopia Conference (virtual), 9/21-9/23 JPMorgan 12th Annual U.S. All Stars Conference (virtual), 9/21-9/23 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual), 9/20-9/23 Roth Capital 8th Annual Solar Symposium (virtual), 9/20-9/23 Sidoti Fall Small Cap Conference (virtual), 9/22-9/23 Wells Fargo 4th Annual Consumer Conference (virtual), 9/22-9/23 Market Closing Prices Yesterday The S&P 500 Index gained 41.45 points, or 0.95%, to 4,395.64 The Dow Jones Industrial Average rose 338.48 points, or 1.00%, to 34,258.32 The Nasdaq Composite jumped 150.45 points, or 1.02%, to 14896.85 The Russell 2000 Index advanced 32.38 points, or 1.48% to 2,218.56 Macro Up/Down Last Nymex -0.32 71.91 Brent -0.27 75.92 Gold 3.80 1,772.00 EUR/USD 0.0028 1.1715 JPY/USD 0.11 109.89 10-Year Note +0.003 1.335% World News China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company (the gov’t will only step in should the company’s failure turn disorderly) – WSJ https://on.wsj.com/3i2x8WH Sector News Breakdown Consumer Steelcase ($SCS) 2Q EPS $0.21 vs est. $0.23 on revs $724.8Mm vs est. $761.3Mm; guides 3Q revs $755-785Mm vs est. $713Mm, sees 3Q EPS $0.07-0.11 vs est. $0.09 Funko ($FNKO) entered into a new credit agreement for a term loan facility of $180M and a revolving credit facility of $100M that mature September 17, 2026 Brilliant Earth ($BRLT)33M share IPO priced at $12.00 Hyatt ($H) 7M share Secondary priced at $74.50 Sovos Brands ($SOVO)3M share IPO priced at $12.00 Energy, Industrials & Materials HB Fuller (FUL) 3Q adj EPS $0.79 vs est. $0.79 on revs $827Mm vs est. $797.6Mm; guides FY revs +17-18% vs est. +14.4%, sees FY adj EBITDA abut $460-470Mm vs est. $463Mm KB Homes (KBH) 3Q EPS $1.60 vs est. $1.62 on revs $1.47B vs est. $1.57B; qtrly homes delivered +35% to $3,425, ending backlog value +89% to $4.84B; inventory +19% to $4.66B as of Aug. 31; repurchased 4.7Mm shares for $188.2Mm Northrop Grumman ($NOC) upgraded to Neutral from Sell at Goldman Sachs with a $350 price target and General Dynamics (GD) also upgraded to Neutral from Sell at Goldman Sachs with a $176 price target in the defense sector; L3Harris Technologies (LHX) downgraded to Sell from Neutral at Goldman Sachs with a $207 price target, Lockheed Martin (LMT) downgraded to Neutral from Buy with $402 tgt and Woodward ($WWD) downgraded to Sell from Neutral with $102 tgt Loop Capital started Regal Beloit Corp (RBC) with a Buy rating and $180 price target and Timken (TKR) with a Hold rating and $72 price target Grinrod Shipping ($GRIN)842M share Spot Secondary priced at $13.50 Syncrude Canada, majority-owned by Suncor Energy ($SU), cut September supplies due to a mechanical disruption at its Alberta oil sands site, Bloomberg reported Financials Chinese Estates (Holdings) Ltd. is planning to sell all of its shares in China Evergrande Group, as the property investment company is worried about the recent stock-price volatility and financial condition of debt-laden Evergrande. Chinese Estates, which currently holds 751.09 million shares or a 5.66% stake in Evergrande, expects to record a realized loss on the stake of about 1.38 billion Hong Kong dollars ($177.2 million) for the year ending December Remitly Global (RELY)16M share IPO priced at $43.00 The9 ($NCTY), Polygon, an Ethereum scaling platform, and Protocol Labs, a major contributor of open-source projects are forming an ecosystem collaboration on NCTY’s Non-Fungible Token (NFT) platform NFTSTAR and GameFi Play-to-Earn projects Safehold (S$AFE)2M share Secondary priced at $76.00 Willis Towers Watson ($WLTW) raises share buyback program by $4B Raymond James Financials ($RJF) posts Private Client Group assets in fee-based accounts of $643.5B grew 33% Y/Y, thanks to the net addition of financial advisers; record client assets under administration of $1.21T rose from $945.2B in the year ago period and $1.18T in the prior month. Healthcare The FDA has granted Emergency Use Authorization for a booster dose of Pfizer ($PFE)/BioNTech’s ($BNTX) COVID-19 vaccine for those 65 and older, those who work in healthcare settings, and adults at high risk of severe COVID-19. The authorization includes people whose “frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19.” Sterling Check (STER)285M share IPO priced at $23.00 Eargo, Inc. (EAR) shares fell -50% on reports it is the target of a criminal investigation by U.S. DOJ related to insurance reimbursement claims submitted on behalf of customers covered by federal employee health plans; the co is withdrawing its financial guidance for fiscal year ending December 31, 2021 Spectrum Pharma (SPPI) Journal of Clinical Oncology Abstract listing for co.’s ‘poziotinib for patients with HER2 exon 20 mutant non–small-cell lung cancer Cigna Corp (CI) named Eric Palmer as president and chief executive officer of Evernorth, its health services unit that mainly houses its pharmacy benefit management business; also announced several other leadership changes Medirom Healthcare (MRM) rises 39%; after saying that it will buy Japanese private hair salon operator Zacc Kabushiki Kaisha in an all-cash deal of 370.0 mln yen ($3.36M) Thorne HealthTech (THRN) 7M share IPO priced at $10.00 Stifel initiated Buy ratings on Mirati Therapeutics (MRTX) with a $202 price target, Kinnate Biopharma (KNTE) with a $32 price target, and Repare Therapeutics (RPTX) with a $48 price target; Hold ratings on Ideaya Biosciences (IDYA) and Revolution Medicines (RVMD) Needham started SAGE Therapeutics (SAGE) at a Buy and added it to its Conviction List; also initiated Buy ratings on Intra-Cellular Therapeutics (ITCI), Avadel Pharmaceuticals (AVDL), Jazz Pharmaceuticals ($JAZZ), Biogen ($BIIB), Harmony Biosciences ($HRMY), and Hold ratings on Neurocrine Biosciences ($NBIX) and ACADIA Pharmaceuticals (ACAD) Technology, Media & Telecom Blackberry ($BB) shares rose 8% after earnings; Q2 EPS ($0.06) vs est. ($0.07) on revenue $175M vs est. $163.5M Facebook ($FB) chief technology officer Mike Schroepfer said in a Facebook post: “After 13 amazing years at Facebook, I have made the decision to step down as Chief Technology Officer and transition to a new part time role as Facebook’s first Senior Fellow at the company sometime in 2022 EngageSmart ($ESMT)55M share IPO priced at $26.00 Roku ($ROKU) upgraded to Buy from Neutral at Guggenheim

106 Replies 7 👍 14 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

147 Replies 13 👍 7 🔥

BR
@Bruce1 #ivtrades
recently

$JAZZ breaking out finally

73 Replies 10 👍 13 🔥

profile
@Dirk07 #robertrother
recently

@Ronin : alles rund um den Bereich Jazz, Pop und Rock, manchmal auch Klassik oder Musical!

119 Replies 12 👍 6 🔥

KH
@khasperg #ivtrades
recently

long $PFE, $BMY, $JAZZ, only thing green

140 Replies 9 👍 15 🔥

BR
@Bruce1 #ivtrades
recently

$JAZZ wants to break out

91 Replies 14 👍 8 🔥

profile
@HeyShoe #droscrew
recently

he had jazz hands on SNL

115 Replies 11 👍 9 🔥

profile
@dros #droscrew
recently

jazz flute?

137 Replies 15 👍 11 🔥

profile
@CarlosH #ivtrades
recently

$JAZZ to $205

87 Replies 10 👍 9 🔥

profile
@Pyrognosis #droscrew
recently

https://www.npr.org/2021/02/11/967082282/chick-corea-jazz-fusion-pioneer-has-died-of-cancer-at-79

146 Replies 13 👍 10 🔥

BR
@Bruce1 #ivtrades
recently

I guess $JAZZ is now a weeder. big

114 Replies 10 👍 11 🔥

profile
@Snowcow #droscrew
recently

buyout by $jazz

115 Replies 10 👍 15 🔥

NI
@nicola75 #decarolis
recently

> @Bebop1276 said: ho per la miseria...che mi sono perso... non va bene, la musica é arte e emozione, e deve unire.. i dj, non suonano, perché il mixer non é uno strumento, come le pornostar non sono artiste anche se ce lo hanno scritto sulla carta d identitá.. il rap, trap e cagate varie rimangono cagate rispetto all anima del rock,, che nasce dal blues e si trasforma da chuck barry in jazz/fusion/rock e svariati rami fino al pop rock degli '90 sono figlio di Jimy hendrix/ e soprattutto non fate girare le bolas a Jp randall

61 Replies 10 👍 6 🔥

NI
@nicola75 #decarolis
recently

> @Bebop1276 said: ho per la miseria...che mi sono perso... non va bene, la musica é arte e emozione, e deve unire.. i dj, non suonano, perché il mixer non é uno strumento, come le pornostar non sono artiste anche se ce lo hanno scritto sulla carta d identitá.. il rap, trap e cagate varie rimangono cagate rispetto all anima del rock,, che nasce dal blues e si trasforma da chuck barry in jazz/fusion/rock e svariati rami fino al pop rock degli '90 sono figlio di Jimy hendrix/ e soprattutto non fate girare le bolas a Jp randall

83 Replies 13 👍 6 🔥

profile
@Bebop1276 #decarolis
recently

ho per la miseria...che mi sono perso... non va bene, la musica é arte e emozione, e deve unire.. i dj, non suonano, perché il mixer non é uno strumento, come le pornostar non sono artiste anche se ce lo hanno scritto sulla carta d identitá.. il rap, trap e cagate varie rimangono cagate rispetto all anima del rock,, che nasce dal blues e si trasforma da chuck barry in jazz/fusion/rock e svariati rami fino al pop rock degli '90 sono figlio di Jimy hendrix/ e soprattutto non fate girare le bolas a Jp randall

93 Replies 11 👍 14 🔥

profile
@ashy2classy #droscrew
recently

you a jazz fan? > @Pyrognosis said: I'm all about Pandora's Art Pepper radio these days

147 Replies 12 👍 6 🔥

profile
@MT #StockTraders.NET
recently

140-142 is what i want for Jazz

72 Replies 13 👍 6 🔥

profile
@viking #StockTraders.NET
recently

@MT $JAZZ working nice for you as well

66 Replies 10 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$JAZZ has very little volume

129 Replies 10 👍 14 🔥

profile
@viking #StockTraders.NET
recently

my thesis was the negative news on that study released yesterday. I should have realized something was up when the price didnt move from the get-go. I have a good source in the valley that told me today to get out. He said " Nah I wouldn't short it. Small cell is tough to treat, this could be a big help And jazz dropped $1B on this drug so they aren't gonna give up easily "

57 Replies 14 👍 15 🔥

profile
@viking #StockTraders.NET
recently

just gave this to @WINTERTRADE but figured Id share with the room in regards to $JAZZ ...

143 Replies 12 👍 9 🔥

profile
@viking #StockTraders.NET
recently

stopped the bleeding on $JAZZ

44 Replies 10 👍 10 🔥

profile
@viking #StockTraders.NET
recently

I am still confused on $JAZZ though, I cant tell if the study released today was positive or negative. if

56 Replies 14 👍 9 🔥

profile
@viking #StockTraders.NET
recently

first red day for me in a few weeks. $PFE and $JAZZ got me. Ive been chasing the winning streak the last couple days and it altered my core strategy so time to get back to what works

72 Replies 15 👍 9 🔥

AL
@albertoc #StockTraders.NET
recently

Jazz buyer on tape slowly withdrawing

98 Replies 9 👍 7 🔥

profile
@MT #StockTraders.NET
recently

last add Jazz ss

150 Replies 13 👍 11 🔥

profile
@viking #StockTraders.NET
recently

$JAZZ interesting moves on the negative news

86 Replies 11 👍 12 🔥

profile
@MT #StockTraders.NET
recently

added ss $JAZZ

120 Replies 9 👍 12 🔥

profile
@MT #StockTraders.NET
recently

ss some JAZZ

141 Replies 12 👍 13 🔥

profile
@MT #StockTraders.NET
recently

watchlist: $LIZI $OMER $ESTC $JAZZ $COGT $CEMI $HDSN

80 Replies 7 👍 12 🔥

profile
@MT #StockTraders.NET
recently

$JAZZ phase 3 results out, did not meet whats needed

76 Replies 13 👍 15 🔥

profile
@dros #droscrew
recently

2400 $JAZZ 18DEC20 $160 Cs bought 2.25

130 Replies 14 👍 14 🔥

profile
@DaveDixon #CoreTrader
recently

US Market US markets closed higher yesterday, amid hopes for an uncontested result from the US presidential election. Arista Networks surged 15.4%, after the company reported a better than expected quarterly profit. Wayfair climbed 7.2%, after the online home decor retailer reported better than expected revenue and earnings in the third quarter. Ferrari jumped 7.0%, as the company reported better than expected revenue and earnings in the third quarter. Jazz Pharmaceuticals advanced 1.0%, as the drugmaker’s third quarter revenue surpassed analysts’ forecast and after it raised its annual revenue forecast. Mondelez International rose 0.2%, following growth in its third quarter revenue and earnings and amid plans to reinstate its share buyback program this quarter. On the flipside, PayPal dropped 4.2%, despite reporting better than anticipated third quarter revenue and earnings. The S&P 500 gained 1.8%, to settle at 3,369.0. The DJIA rose 2.1%, to settle at 27,480.0, while the NASDAQ added 1.9%, to close at 11,160.6 .

42 Replies 12 👍 11 🔥

profile
@Brandon #
recently

Upgrades: ABEV ANET MNST PAYC PDD STZ Downgrades: GHL IPGP MOS PACB SEDG MktWgt: GILD QSR Outperf: JAZZ PTON Buy: KRON Earnings Triple Plays: ANET CDK CRUS IT JAZZ MCK SWKS TREK ZBRA Data: 10a Factory Orders (1.0), 10am ex-Transports (0.6), 10a Durable Goods (1.9), 10a ex-Transports (0.8) Yesterday's Movers:

68 Replies 11 👍 7 🔥

profile
@CarlosH #ivtrades
recently

$JAZZ to $202

87 Replies 6 👍 15 🔥

profile
@AntonioMangano #decarolis
recently

un po' di jazz :D

104 Replies 13 👍 11 🔥

profile
@ashy2classy #droscrew
recently

i was thinking it meant i had to buy and sell and lease and all that jazz ;o)

143 Replies 6 👍 7 🔥

profile
@CarlosH #ivtrades
recently

Good morning $JAZZ raised to $182

92 Replies 10 👍 15 🔥

profile
@xhulio007 #decarolis
recently

con questa meglio che sto zito hahahaha > @jprandall said: non era proprio jazz quello del Genius, direi soul /rhythm and blues ...ma va bene ! 😉 👍

89 Replies 8 👍 15 🔥

profile
@jprandall #decarolis
recently

non era proprio jazz quello del Genius, direi soul /rhythm and blues ...ma va bene ! 😉 👍

147 Replies 11 👍 11 🔥

profile
@xhulio007 #decarolis
recently

@jprandall un grande bello il jazz

97 Replies 10 👍 13 🔥

profile
@Gary19 #droscrew
recently

I never really got into jazz. Or country lol

137 Replies 10 👍 9 🔥

profile
@dros #droscrew
recently

just kidding btw pyro, I dig the good jazz

134 Replies 9 👍 14 🔥

profile
@dros #droscrew
recently

jazz had some nice flow earlier in the week too

139 Replies 8 👍 8 🔥

profile
@Pyrognosis #droscrew
recently

wtf is JAZZ?

102 Replies 6 👍 10 🔥

Key Metrics

Market Cap

8.89 B

Beta

0

Avg. Volume

583.98 K

Shares Outstanding

61.36 M

Yield

0%

Public Float

0

Next Earnings Date

2021-11-01

Next Dividend Date

Company Information

Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines that transform the lives of patients with serious diseases - often with limited or no options. Jazz Pharmaceuticals plc has a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. The company's focus is in neuroscience, including sleep and movement disorders, and in oncology, including hematologic and solid tumors. They actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries.

Website:

HQ: Fifth Floor, Waterloo Road,Dublin 4 Waterloo Exchange

Related News